Geratherm Medical AG (FRA:GME)

Geratherm Medical AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.64	7.68	5.24	8.74	2.26	4.85
Short-Term Investments	1.96	1.97	2.51	2.15	4.21	5.41
Cash & Short-Term Investments	9.61	9.64	7.74	10.89	6.47	10.26
Cash Growth	51.72%	24.52%	-28.85%	68.25%	-36.95%	7.54%
Accounts Receivable	1.58	1.19	1.81	3.78	3.18	3.21
Other Receivables	-	-	-	-	1.05	0.25
Receivables	1.58	1.19	1.81	3.78	4.23	3.46
Inventory	4.05	5.56	9.36	7.03	8.54	7.31
Other Current Assets	2.44	1.99	1.97	1.63	0.38	0.38
Total Current Assets	17.68	18.39	20.88	23.32	19.61	21.4
Property, Plant & Equipment	7.35	7.67	9.45	9.99	9.32	9.68
Long-Term Investments	0.73	0.73	0.63	0.63	1.37	1.72
Goodwill	-	-	0.07	0.08	0.09	0
Other Intangible Assets	1.66	1.61	4.56	4.04	1.07	0.3
Long-Term Deferred Charges	-	-	-	-	2.99	2.78
Other Long-Term Assets	0.12	0.14	0.13	0.33	0.1	0.12
Total Assets	27.53	28.54	35.72	38.38	34.56	35.99
Accounts Payable	0.8	0.8	0.85	1.51	1.43	1.5
Accrued Expenses	-	1.51	2.46	2.45	1.68	1.49
Current Portion of Long-Term Debt	-	1.62	-	-	2.84	3.2
Current Portion of Leases	-	-	-	-	0.28	0.25
Current Income Taxes Payable	0.09	0.09	0.06	0.14	0.05	0.08
Current Unearned Revenue	-	-	-	-	1.76	0.89
Other Current Liabilities	2.34	0.51	0.13	0.22	0.39	0.41
Total Current Liabilities	3.23	4.53	3.5	4.31	8.43	7.83
Long-Term Debt	2.62	1.66	7.23	9.29	5.95	6.62
Long-Term Leases	-	-	-	-	0.25	0.33
Long-Term Unearned Revenue	0.85	0.9	1.43	1.52	1.29	1.23
Long-Term Deferred Tax Liabilities	0.17	0.18	0.03	0.03	0.01	0.05
Other Long-Term Liabilities	0.08	0.44	0.92	1	-	-
Total Liabilities	6.95	7.71	13.11	16.15	15.93	16.07
Common Stock	5.41	5.41	5.41	5.44	4.95	4.95
Retained Earnings	-0.39	-0.2	-0.37	-0.66	-0.64	1.27
Comprehensive Income & Other	15.8	15.81	17.29	17.56	14.21	14.08
Total Common Equity	20.83	21.02	22.33	22.34	18.52	20.3
Minority Interest	-0.25	-0.2	0.28	-0.11	0.11	-0.38
Shareholders' Equity	20.58	20.82	22.61	22.23	18.63	19.93
Total Liabilities & Equity	27.53	28.54	35.72	38.38	34.56	35.99
Total Debt	2.62	3.28	7.23	9.29	9.32	10.4
Net Cash (Debt)	6.99	6.37	0.51	1.59	-2.85	-0.14
Net Cash Growth	-	1138.95%	-67.71%	-	-	-
Net Cash Per Share	-	1.18	0.09	0.29	-0.58	-0.03
Filing Date Shares Outstanding	-	5.41	5.38	5.44	4.95	4.95
Total Common Shares Outstanding	-	5.41	5.38	5.44	4.95	4.95
Working Capital	14.45	13.86	17.38	19	11.18	13.57
Book Value Per Share	-	3.88	4.15	4.10	3.74	4.10
Tangible Book Value	19.17	19.41	17.7	18.21	17.36	20.01
Tangible Book Value Per Share	-	3.59	3.29	3.35	3.51	4.04
Land	-	7.09	7.33	7.33	7.35	7.23
Machinery	-	13.83	14.36	14.44	13.27	12.86
Construction In Progress	-	-	0.03	0.84	0.31	0.37
Order Backlog	-	-	-	-	0.08	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.